Synthego

FromSynthego ([email protected])
Subject (58)Introducing New IND-enabling sgRNA for Preclinical Studies
Preheader (108)Discover Synthego's new IND-enabling sgRNA, designed for preclinical safety, toxicity, and efficacy studies.
Typography
sans
Colors
Text Analysis
Body Words258
Subject Words7
Body Emojis1
Subject Emojis
Media Analysis
Text Links7
Image Links7
Total Links14
Images9
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px1712 px
X-Spam Score-5.1
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeAfternoon

Introducing New IND-enabling sgRNA for Preclinical Studies

Discover Synthego's new IND-enabling sgRNA, designed for preclinical safety, toxicity, and efficacy studies.
Introducing New IND-enabling sgRNA for Preclinical Studies